Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 64, Issue 2, Pages 159-171Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2007.03.001
Keywords
erythropoietin; receptor; neuroprotection; blood-brain barrier; ischemic preconditioning; brain ischemia; Neurogenesis; endothelium
Categories
Funding
- Intramural NIH HHS [Z99 DK999999, Z01 DK025061-32] Funding Source: Medline
Ask authors/readers for more resources
Multi-tissue erythropoietin receptor (EPO-R) expression provides for erythropoietin (EPO) activity beyond its known regulation of red blood cell production. This review highlights the role of EPO and EPO-R in brain development and neuroprotection. EPO-R brain expression includes neural progenitor cells (NPC), neurons, glial cells and endothelial cells. EPO is produced in brain in a hypoxia sensitive manner, stimulates NPC proliferation and differentiation, and neuron survival, and contributes to ischemic preconditioning. Mice lacking EPO or EPOR exhibit increased neural cell apoptosis during development before embryonic death due to severe anemia. EPO administration provides neural protection in animal models of brain ischemia and trauma, reducing the extent of injury and damage. Intrinsic EPO production in brain and EPO stimulation of endothelial cells contribute to neuroprotection and these are of particular importance since only low levels of EPO appear to cross the blood-brain barrier when administered at high dose intravenously. The therapeutic potential of EPO for brain ischemia/trauma and neurodegenerative diseases has shown promise in early clinical trial and awaits further validation. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available